Article
ABCA1 gene variation and heart disease risk reduction in the elderly during pravastatin treatment.
Atherosclerosis - 1 Jul 2014
Akao Hironobu, Polisecki Eliana, Schaefer Ernst J, Trompet Stella, Robertson Michele, Ford Ian, Jukema J Wouter, de Craen Anton J M, Packard Christopher, Buckley Brendan M, Kajinami Kouji
Abstract excerpt
AIMS: Our goals were to examine the relationships of a specific ATP-binding cassette transporter A1 (ABCA1) variant, rs2230806 (R219K), on baseline lipids, low-density lipoprotein cholesterol (LDL-C) lowering due to pravastatin, baseline heart disease, and cardiac endpoints on trial. METHODS AND RESULTS: The ABCA1 R219K variant was assessed in 5414 participants in PROSPER (PROspective Study of Pravastatin in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
